<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transient global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> results in selective neuronal damage of hippocampal CA1 neurons </plain></SENT>
<SENT sid="1" pm="."><plain>Five minutes of bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp>, in the Mongolian gerbil, effectively restricts forebrain blood flow, resulting in a delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo> of CA1 pyramidal cells </plain></SENT>
<SENT sid="2" pm="."><plain>While there is a delay of approximately 72 h in the appearance of cell <z:hpo ids='HP_0011420'>death</z:hpo>, markers related to the mechanism of ischemic <z:hpo ids='HP_0011420'>death</z:hpo> become apparent well before neurons die </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e>-induced increases in the cell-<z:hpo ids='HP_0011420'>death</z:hpo>-promoting protein, bax, may disrupt the bcl-2/bax ratio necessary for <z:mpath ids='MPATH_458'>normal</z:mpath> neuronal functioning and thus promote transient ischemic <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In order to locally maintain this critical bcl-2/bax ratio and thus protect CA1 neurons from delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo>, a <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> <z:mp ids='MP_0001799'>viral</z:mp> (HSV) vector was used to selectively introduce human bcl-2, under the control of the <z:e sem="disease" ids="C0019340" disease_type="Disease or Syndrome" abbrv="">herpes</z:e> IE 4/5 promoter, into the CA1 region of the gerbil hippocampus </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty-four hours prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> surgery, 1 microl of HSVbcl-2 was infused unilaterally into the CA1 region at a rate of 2 nl/min </plain></SENT>
<SENT sid="6" pm="."><plain>Seventy-two hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> the animals were sacrificed and processed using Nissl, silver degeneration, and immunohistochemical (anti-human bcl-2) staining </plain></SENT>
<SENT sid="7" pm="."><plain>Immunohistochemistry demonstrated both glial and neuronal bcl-2 expression around the HSVbcl-2 infusion site </plain></SENT>
<SENT sid="8" pm="."><plain>The evaluation following silver degeneration staining indicated a further degeneration of CA1 neurons in the immediate area of the <z:mp ids='MP_0001799'>viral</z:mp> vector infusion </plain></SENT>
<SENT sid="9" pm="."><plain>This damage seems to be the result of cellular debris associated with the processing of the <z:mp ids='MP_0001799'>viral</z:mp> amplicons </plain></SENT>
<SENT sid="10" pm="."><plain>Silver degeneration staining is not present in the areas that demonstrate bcl-2 staining </plain></SENT>
<SENT sid="11" pm="."><plain>These neurons appear to have been rescued from ischemic damage </plain></SENT>
<SENT sid="12" pm="."><plain>This result was confirmed using the Nissl staining </plain></SENT>
<SENT sid="13" pm="."><plain>Therefore, by altering the local ratio of bcl-2/bax using the HSVbcl-2 vector one may protect CA1 pyramidal cell from the delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo> of transient global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>